-
Featured
Identifying Risk Factors for Type 2 Myocardial Infarction
In one of the first large systematic surveys of the frequency and implications of supply/demand-related Type 2 Myocardial Infarction, a suite of risk factors has been identified to help ensure patients receive proper care.
-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
DNA is not Destiny When it Comes to Heart Attack Risk
A study led by Sekar Kathiresan, MD, of Mass General, has found that having a favorable lifestyle can help those with a high genetic risk of having a heart attack reduce their risk by over 50%.
-
Role of Cardiologists in Evaluation of Type 2 Myocardial Infarction Unclear
Cian P. McCarthy, MB, BCh, BAO, and Jason H. Wasfy, MD, MPhil, of the Division of Cardiology, documented significant differences in testing and treatment between patients with type 2 myocardial infarction who were or were not evaluated by a cardiologist during admission, but the effect on outcomes is still unclear.
-
STEMI Due to Plaque Rupture Most Likely to Occur in Morning
Acute myocardial infarction caused by plaque rupture may be related to catecholamine surge in the morning.
-
Pathologic Link Detected Between COVID-19 and Myocarditis
Levels of ACE2, the receptor for SARS-CoV-2, are increased in cardiomyocytes but are not affected by ACE inhibitors.
Myocardial Infarction contributors
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
TRANSFORM HFrEF Study Aims to Improve HF Outcomes
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Assistant Professor of Medicine, Harvard Medical School
Recent Article
CV Risk Associated with Premature Menopause: Clonal Hematopoiesis May Contribute
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
